why choose us

300×250 Ad Slot

Research Article: Changes in Oral Corticosteroid Utilization in Patients with COPD Following Initiation of FF/UMEC/VI

Date Published: 2023-11-01

Introduction:
Oral corticosteroids (OCS) are used to treat acute chronic obstructive pulmonary disease (COPD) exacerbations, although use should be limited to days. Chronic OCS use is not recommended due to the high rate of systemic complications associated with their use, including respiratory muscle deterioration, immunosuppression, increased blood glucose, increased blood pressure, and adrenal suppression. – Prolonged use of high dose OCS has been shown to contribute to the development of comorbidities such as diabetes,…

Read more

300×250 Ad Slot